Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Tactiva Therapeutics
551 Franklin Street
Buffalo, NY 14202
Phone: 716-536-2971
http://tactivatherapeutics.com/

Tactiva is a development stage immuno-oncology company with a unique approach to adoptive T-cell therapy. Tactiva's dual enhanced adoptive cell therapy (DEACT™) platform, consists of engineered CD4/CD8 cells which generate a durable supply of CD4 cells with direct anti-tumor activity as well as sustained helper function to CD8 T cell derived TCR-transduced effector T cells. Tactiva Therapeutics is working to develop the next generation of cancer immunotherapies by utilizing a new approach to cell therapy. This type of personalized cancer treatment enhances the patient's immune system ability to tackle the disease.

Key Contact
Name
Matthew Colpoys
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/03/18 $35,000,000 Series A Efung Capital
Panacea Ventures
Vi-Ventures
undisclosed


Featured Reading